Syndecan-4 Signaling Is Required for Exercise-Induced Cardiac Hypertrophy

Molecular Medicine
Jun XieBiao Xu

Abstract

Cardiac hypertrophy can be broadly classified as either physiological or pathological. Physiological stimuli such as exercise cause adaptive cardiac hypertrophy and normal heart function. Pathological stimuli including hypertension and aortic valvular stenosis cause maladaptive cardiac remodeling and ultimately heart failure. Syndecan-4 (synd4) is a transmembrane proteoglycan identified as being involved in cardiac adaptation after injury, but whether it takes part in physiological cardiac hypertrophy is unclear. We observed upregulation of synd4 in exercise-induced hypertrophic myocardium. To evaluate the role of synd4 in the physiological form of cardiac hypertrophy, mice lacking synd4 (synd4-/-) were exercised by swimming for 4 wks. Ultrasonic cardiogram (UCG) and histological analysis revealed that swimming induced the hypertrophic phenotype but was blunted in synd4-/- compared with wild-type (WT) mice. The swimming-induced activation of Akt, a key molecule in physiological hypertrophy was also more decreased than in WT controls. In cultured cardiomyocytes, synd4 overexpression could induce cell enlargement, protein synthesis and distinct physiological molecular alternation. Akt activation also was observed in synd4-overexp...Continue Reading

References

Nov 14, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M IemitsuI Yamaguchi
Jun 29, 2002·Circulation Research·Ichiro Shiojima, Kenneth Walsh
Jul 11, 2002·Journal of the American College of Cardiology·Víctor G Dávila-RománRobert J Gropler
Sep 6, 2002·The New England Journal of Medicine·JoAnn E MansonDavid S Siscovick
Sep 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Julie R McMullenSeigo Izumo
Dec 13, 2003·The Biochemical Journal·Eunyoung KeumEok-Soo Oh
Dec 20, 2003·Nature Reviews. Molecular Cell Biology·John R Couchman
Apr 26, 2006·Circulation·Brian DeBoschAnthony J Muslin
Feb 28, 2007·Clinical and Experimental Pharmacology & Physiology·Julie R McMullen, Garry L Jennings
Oct 18, 2007·Journal of Cellular Physiology·Ole Johan KemiOyvind Ellingsen
May 15, 2008·The Journal of Biological Chemistry·Meriem BourajjajLeon J De Windt
Apr 24, 2009·The Journal of Biological Chemistry·Evgeny A ZemskovAlexey M Belkin
Sep 12, 2009·Journal of Molecular and Cellular Cardiology·Hiroyuki IkedaIssei Komuro
Nov 19, 2009·The Journal of Clinical Investigation·Hiroyuki NakayamaJeffery D Molkentin
Jun 23, 2010·Annual Review of Cell and Developmental Biology·John R Couchman
Oct 20, 2010·Circulation·Peter Kokkinos, Jonathan Myers
Apr 16, 2011·Circulation Research·Yutaka MatsuiToshimitsu Uede
Jun 3, 2011·Cardiovascular Research·Frank EchtermeyerGregor Theilmeier
Jul 5, 2011·European Journal of Heart Failure·Antoine H Chaanine, Roger J Hajjar
Sep 10, 2011·The FEBS Journal·Alexey M Belkin
May 9, 2012·Journal of Molecular and Cellular Cardiology·Jun XieBiao Xu
Sep 15, 2012·Cellular Signalling·Rong Ju, Michael Simons
Feb 5, 2014·Journal of Molecular and Cellular Cardiology·Katsuhito Fujiu, Ryozo Nagai

❮ Previous
Next ❯

Citations

Jul 5, 2016·International Journal of Molecular Sciences·Shudong WangYang Zheng
Jun 6, 2020·Annual Review of Biomedical Engineering·Erica A CastilloBeth L Pruitt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.